The Extremal Function for the Complex Ball for Generalized Notions of Degree and Multivariate Polynomial Approximation

We discuss the Siciak-Zaharjuta extremal function of pluripotential theory for the unit ball in C^d for spaces of polynomials with the notion of degree determined by a convex body P. We then use it to analyze the approximation properties of such polynomial spaces, and how these may differ depending on the function f to be approximated

Evaluating GaN Doherty architectures for 4G Picocells, WiMax and microwave backhaul links

This paper evaluates the Doherty power amplifier architecture in terms of linearity, efficiency and design solutions. As case study four different prototypes are presented, one for 4G Picocells at 2.1 GHz, one for WiMax applications at 3.5 GHz and two for point-to-point microwave backhaul radiolinks at 7 GHz. Experimental results together with design guidelines are discussed addressing strengths and weaknesses of the Doherty architectur

Microfluidic-based immunohistochemistry for breast cancer diagnosis: a comparative clinical study.

Breast cancer is a highly heterogeneous disease. The efficacy of tailored therapeutic strategies relies on the precise detection of diagnostic biomarkers by immunohistochemistry (IHC). Therefore, considering the increasing incidence of breast cancer cases, a concomitantly time-efficient and accurate diagnosis is clinically highly relevant. Microfluidics is a promising innovative technology in the field of tissue diagnostic, enabling for rapid, reliable, and automated immunostaining. We previously reported the microfluidic-based HER2 (human epidermal growth factor receptor 2) detection in breast carcinomas to greatly correlate with the HER2 gene amplification level. Here, we aimed to develop a panel of microfluidic-based IHC protocols for prognostic and therapeutic markers routinely assessed for breast cancer diagnosis, namely HER2, estrogen/progesterone receptor (ER/PR), and Ki67 proliferation factor. The microfluidic IHC protocol for each marker was optimized to reach high staining quality comparable to the standard procedure, while concomitantly shortening the staining time to 16 min-excluding deparaffinization and antigen retrieval step-with a turnaround time reduction up to 7 folds. Comparison of the diagnostic score on 50 formaldehyde-fixed paraffin-embedded breast tumor resections by microfluidic versus standard staining showed high concordance (overall agreement: HER2 94%, ER 95.9%, PR 93.6%, Ki67 93.7%) and strong correlation (ρ coefficient: ER 0.89, PR 0.88, Ki67 0.87; p < 0.0001) for all the analyzed markers. Importantly, HER2 genetic reflex test for all discordant cases confirmed the scores obtained by the microfluidic technique. Overall, the microfluidic-based IHC represents a clinically validated equivalent approach to the standard chromogenic staining for rapid, accurate, and automated breast cancer diagnosis

Nitrogen isotopic composition as a gauge of tumor cell anabolism-to-catabolism ratio.

Studies have suggested that cancerous tissue has a lower <sup>15</sup> N/ <sup>14</sup> N ratio than benign tissue. However, human data have been inconclusive, possibly due to constraints on experimental design. Here, we used high-sensitivity nitrogen isotope methods to assess the <sup>15</sup> N/ <sup>14</sup> N ratio of human breast, lung, and kidney cancer tissue at unprecedented spatial resolution. In lung, breast, and urothelial carcinoma, <sup>15</sup> N/ <sup>14</sup> N was negatively correlated with tumor cell density. The magnitude of <sup>15</sup> N depletion for a given tumor cell density was consistent across different types of lung cancer, ductal in situ and invasive breast carcinoma, and urothelial carcinoma, suggesting similar elevations in the anabolism-to-catabolism ratio. However, tumor <sup>15</sup> N depletion was higher in a more aggressive metaplastic breast carcinoma. These findings may indicate the ability of certain cancers to more effectively channel N towards growth. Our results support <sup>15</sup> N/ <sup>14</sup> N analysis as a potential tool for screening biopsies and assessing N metabolism in tumor cells

Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression.

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by numerous fluid-filled cysts that frequently result in end-stage renal disease. While promising treatment options are in advanced clinical development, early diagnosis and follow-up remain a major challenge. We therefore evaluated the diagnostic value of Fetuin-A as a new biomarker of ADPKD in human urine. RESULTS: We found that renal Fetuin-A levels are upregulated in both Pkd1 and Bicc1 mouse models of ADPKD. Measurement by ELISA revealed that urinary Fetuin-A levels were significantly higher in 66 ADPKD patients (17.5 ± 12.5 μg/mmol creatinine) compared to 17 healthy volunteers (8.5 ± 3.8 μg/mmol creatinine) or 50 control patients with renal diseases of other causes (6.2 ± 2.9 μg/mmol creatinine). Receiver operating characteristics (ROC) analysis of urinary Fetuin-A levels for ADPKD rendered an optimum cut-off value of 12.2 μg/mmol creatinine, corresponding to 94% of sensitivity and 60% of specificity (area under the curve 0.74 ; p = 0.0019). Furthermore, urinary Fetuin-A levels in ADPKD patients correlated with the degree of renal insufficiency and showed a significant increase in patients with preserved renal function followed for two years. CONCLUSIONS: Our findings establish urinary Fetuin-A as a sensitive biomarker of the progression of ADPKD. Further studies are required to examine the pathogenic mechanisms of elevated renal and urinary Fetuin-A in ADPKD

Ocorrência de hematomas e lesões em carcaças bovinas e sua relação com o transporte rodoviário

Objetivou-se avaliar a incidência de hematomas e perdas por lesões em carcaças bovinas de animais submetidos ao transporte rodoviário. Foram avaliadas 1599 carcaças quanto ao número de hematomas e 1440 quanto as perdas por lesões. O estudo foi conduzido no município de Aquidauana/MS, em frigorífico local. Avaliou-se visualmente o número, localização, coloração e tamanho dos hematomas. Além disso, foram coletados dados referentes aos tipos de caminhões, distância percorrida até o frigorífico, classe sexual e idade dos animais. Para quantificar as lesões, realizou-se a coleta e pesagem das lesões retiradas durante a toalete final das carcaças. Das carcaças avaliadas quanto aos hematomas, 97,81% apresentaram um ou mais hematomas. Além disso, a região sacral obteve a maior percentagem média de hematomas (31,77%). A coloração mais presente nas carcaças avaliadas foi a de número 2 (púrpura), com 67,75%. Foi encontrada maior incidência de hematomas de tamanho 2 (26 a 36 cm2), com 29,51%. Já em relação ao tipo de caminhão, os animais transportados por veículo tipo Julieta apresentaram maior número de hematomas. Do total de animais avaliados para lesões, 61,32% apresentaram, totalizando 324,36 kg de lesões retiradas na toalete final da linha de abate, o que representou uma perda econômica de R$ 3.091,41. A alta incidência de hematomas e lesões em carcaças bovinas ocorre predominantemente durante o transporte, no manejo pré-abate, gerando detrimento da qualidade das carcaças e perdas econômicas

Postmortem Cardiopulmonary Pathology in Patients with COVID-19 Infection: Single-Center Report of 12 Autopsies from Lausanne, Switzerland.

We report postmortem cardio-pulmonary findings including detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in formalin-fixed paraffin embedded tissue in 12 patients with COVID-19. The 5 women and 7 men (median age: 73 years; range 35-96) died 6-38 days after onset of symptoms (median: 14.5 days). Eight patients received mechanical ventilation. Ten patients showed diffuse alveolar damage (DAD), 7 as exudative and 3 as proliferative/organizing DAD. One case presented as acute fibrinous and organizing pneumonia. Seven patients (58%) had acute bronchopneumonia, 1/7 without associated DAD and 1/7 with aspergillosis and necrotic bronchitis. Microthrombi were present in 5 patients, only in exudative DAD. Reverse transcriptase quantitative PCR detected high virus amounts in 6 patients (50%) with exudative DAD and symptom-duration ≤14 days, supported by immunohistochemistry and in-situ RNA hybridization (RNAscope). The 6 patients with low viral copy levels were symptomatic for ≥15 days, comprising all cases with organizing DAD, the patient without DAD and one exudative DAD. We show the high prevalence of DAD as a reaction pattern in COVID-19, the high number of overlying acute bronchopneumonia, and high-level pulmonary virus detection limited to patients who died ≤2 weeks after onset of symptoms, correlating with exudative phase of DAD

Analysis of the effects of depression associated polymorphisms on the activity of the BICC1 promoter in amygdala neurones

ACKNOWLEDGMENTS This work was funded by The BBSRC (BB/D004659/1) the Wellcome Trust (080980/Z/06/Z) and the Medical Research Council (G0701003).Peer reviewedPublisher PD